Andrew Smith, MD, PhD

Andrew Smith, MD, PhD 


August 26, 2022 — AI Metrics, an early stage radiology software company, announces changes to its executive leadership team, naming Dr. Andrew Smith as Chief Medical Officer and appointing Bob Jacobus as CEO. 

AI Metrics, launched in 2019 by Jacobus, Paige Severino, and radiologist and researcher Dr. Smith is developing software to more accurately assess cancer treatment effectiveness. The founders set out to leverage augmented intelligence in innovative imaging software solutions, improve radiology workflows, quantitative metrics, and reporting in clinical practice and clinical trials. 

Dr. Smith, the Company’s initial CEO, will take on the newly created role of Chief Medical Officer while continuing his role as Chairman of the Board. Dr. Smith is currently a Radiologist and Oncologic Imager at the University of Alabama at Birmingham. He is Vice Chair of Clinical Research, Chief of Body CT, and is also the Clinical Director of AI at the University’s Heersink Institute of Biomedical Innovation

“I am excited to take on the role of Chief Medical Officer at AI Metrics, where I will be able to focus on the clinical aspects, the necessary research and new and innovative advancements needed in radiology and cancer treatment evaluation,” said Dr. Smith. “AI Metrics was created to utilize advanced technologies to help standardize reporting with greater inter-observer agreement, while decreasing variations in impressions – making it more useful and easier for oncologists to interpret data and information for their patients.” 

Jacobus was the company’s initial COO and has more than 20 years of experience in founding, investing in and raising capital for startups. He is an experienced financial professional, with significant industry experience in investment banking, early-stage ventures, financial management, new business development, engineering, operations, and manufacturing. Jacobus also has deep experience in the biotech, medical products manufacturing, software, transportation and insurance sectors. 

​​"I am honored to lead this innovative company that is delivering solutions to radiologists who work on important issues such as saving lives and working with advanced cancers,” said Jacobus. “My role as CEO is to lead AI Metrics as it helps solve real radiology pain points using AI technologies to improve accuracy, consistency, and efficiency in radiology.” 

For more information: https://www.aimetrics.com/ 

 


Related Content

News | Radiation Oncology

July 10, 2026 — A new study led by researchers at the Icahn School of Medicine at Mount Sinai found that although the ...

Time July 10, 2026
arrow
News | PACS

July 8, 2026 — Freeland Systems, a cloud PACS and clinical imaging software company, has launched its new customer ...

Time July 10, 2026
arrow
News | Ultrasound Imaging

July 7, 2026 — Longeviti Neuro Solutions has launched a new strategic initiative, ClearFit AI, a Brain Ultrasound ...

Time July 09, 2026
arrow
News | Prostate Cancer

July 8,2026 — CorePlus, Puerto Rico’s fully digital precision pathology and clinical laboratory, has announced the ...

Time July 08, 2026
arrow
News | Women's Health

July 1, 2026 — Despite declining birth rates worldwide, the complexity of pregnancy is increasing. Advanced maternal age ...

Time July 01, 2026
arrow
News | Information Technology

June 26, 2026 — Radin Health recently announced the successful deployment of its cloud-native platform at four ...

Time June 26, 2026
arrow
News | FDA

June 25, 2026 — Aidoc recently announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Device ...

Time June 25, 2026
arrow
News | Interventional Radiology

June 25, 2026 — Radiologists performing no interventional radiology-related (IR-related) work increased from one-third ...

Time June 25, 2026
arrow
News | Mammography

June 23, 2026 — Using artificial intelligence (AI), researchers found that image-based risk scores for breast cancer ...

Time June 24, 2026
arrow
News | Pediatric Imaging

June 16, 2026 — Crescom has officially launched a global clinical Proof of Concept (PoC) of its pediatric ...

Time June 24, 2026
arrow
Subscribe Now